• Thurs news: Sage R&D layoffs. Another Sanofi radiopharma deal. Novartis loses bid to block generic. Kezar lupus trial stopped. Why are so many pharmacies closing. See more on our front page

roche

  1. Anyone else nervous the Swiss support Russia?

    Yikes! Switzerland just refused to enforce E.U. sanctions against Russian subsidiaries! Here's a free P.S.A.: As the U.S.A. and its allies pivot to a war economy, it may start to be hard to work at companies owned by our enemies (their revenue supports their war effort). Those companies may...
  2. Roche IT reorg again?

    Another Roche IT reorg bcs of huge overspend? How many this time...?
  3. Need Info Roche SARS-CoV-2 Test for COVID-19.

    I'm doing some pro-bono research and consulting on the questions below regarding Roche SARS-CoV-2 Test for COVID-19. I AM NOT consulting or working for Roche! Has a cost or price been established for this test (lab &/or patient)? How many cobas® 6800 and cobas® 8800 Systems are installed in...
  4. Age discrimination at Roche

    During a recent interview with Roche HR, I was asked "What year did you graduate" There was no attempt to hide this blatant discrimination. I answered the question and the call ended quickly. How many people over 50 at Roche are let go, forced out, or not considered for roles because of their age?
  5. Pioneer Ecosystems phone calls Day 1- how bad was it??

    Pioneer Ecosystems phone calls Day 1... how bad was it??
  6. Achaogen ZEMDRI® (plazomicin) Which Pharma

    Which Pharma will get their hands on this. Zemdri now FDA approved and exclusivity at least to 2031 or 2032 and EMA approval ahead Roche. ...Pfizer. ...Sanofi. ... Merck. ... GSK (GlaxoSmithKline) ...AstraZeneca. ...Bayer...Johnson & Johnson. who will outbid who
  7. Eylea / Lucentis Sales Force

    Hi All, I was wondering how big the Eylea and Lucentis US-only sales forces are? I found this tool, but wasn't sure how accurate the information was. https://mddetails.com/insights/u-s-sales-force-estimator/ Thanks!
  8. Roche’s latest trials prove wider use of new drug Hemlibra

    Just a month after picking an accelerated review by U.S. regulators for its new blockbuster drug Hemlibra, Roche has now reported new data from two clinical trials that state the drug effectively cut down the bleeding episodes on patients with Hemophilia A for whom blood does not clot due to...
  9. Will Merck benefit from this acquisition?

    Merck strengthens its oncology platform by acquiring Viralytics for $394 million Merck has announced its first acquisition in the year 2018. Hope this deal benefits Merck.
  10. Sandra Trump

    Really?: "While we all understand the need for ongoing change intellectually, the fact of the matter is that humans don’t like change personally." She made a mess and lays you off because of it, but hey: intellectually you understand why you have to go right? Sandra Horning...
  11. Roche's Tarceva versus Lilly's Verzenio

    Eli Lilly announces results of the Phase 3 JUNIPER trial study for Verzenio. Lilly gets a setback.
  12. Big setback for Lilly

    Verzenio fails and Levi Garraway says the outcome is unfortunate.